School of Medicine


Showing 1-100 of 150 Results

  • Kimberly Allison

    Kimberly Allison

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Allison’s clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as ER and HER2 testing), the utility of molecular panel-based testing in breast cancer, digital pathology applications and identifying the most appropriate management of specific pathologic diagnoses.

  • Euan A. Ashley

    Euan A. Ashley

    Associate Dean, School of Medicine, Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Susan Atwater

    Susan Atwater

    Clinical Associate Professor, Pathology

    Current Research and Scholarly Interests I am interested in optimizing the process of diagnosing leukemias, lymphomas and other hematolymphoid neoplasms, particularly by the use of diagnostic flow cytometry. One goal is to develop flow data analysis processes that function as interactive tools, allowing pathologists to query rich diagnostic data sets in real time.

  • Jeffrey Axelrod

    Jeffrey Axelrod

    Professor of Pathology

    Current Research and Scholarly Interests Genetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.

  • Steven Andrew Baker

    Steven Andrew Baker

    Clinical Instructor, Pathology

    Bio Dr. Steven Baker is a clinical instructor in the Department of Pathology. He graduated from Cornell University with a B.S. in Biological Sciences before completing an M.D. and Ph.D., in Developmental Biology, at Baylor College of Medicine. Clinically he specializes in the laboratory analysis of hemostatic disorders.

  • Niaz Banaei

    Niaz Banaei

    Professor of Pathology and of Medicine (Infectious Diseases) at the Stanford University Medical Center

    Current Research and Scholarly Interests His research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.

  • Ellen Jo Baron

    Ellen Jo Baron

    Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests No current scientific activities. I am retired.

  • Dr. Gregory Bean

    Dr. Gregory Bean

    Assistant Professor of Pathology at the Stanford University Medical Center

    Bio Dr. Bean is an Assistant Professor who specializes in breast pathology. His research interests include molecular characterization of breast cancer subtypes and precursors. He is also involved with the training of residents and fellows on the breast service.

  • Sean Bendall

    Sean Bendall

    Assistant Professor (Research) of Pathology

    Current Research and Scholarly Interests Our goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF ? Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ?normal? human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.

  • Gerald Berry

    Gerald Berry

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Cardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology

  • David Bingham

    David Bingham

    Clinical Assistant Professor, Pathology

    Bio David Bingham MD is a clinical assistant pathologist specializing in gastrointestinal pathology. He is from Connecticut, graduated from Yale with a BA, and went to Columbia P&S for medical school. He did a residency in Pathology at Stanford University, graduated in 1992 and has been here ever since as a faculty member.

  • Matthew Bogyo

    Matthew Bogyo

    Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly Interests Our lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:

    1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.

    2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.

    3) Defining the specific functional roles of proteases during the process of tumorogenesis.

    4) In vivo imaging of protease activity

  • Donald Born

    Donald Born

    Clinical Professor, Pathology

    Bio Dr. Born obtained his medical degree from the University of Virginia where he also completed a Ph.D. in Neuroscience. His next training occurred at the University of Washington as an Anatomic Pathology resident and Neuropathology fellow. He moved to Stanford in 2013 and as Clinical Professor of Pathology he sees a wide range of samples related to the field of neuropathology.

  • Scott Boyd, MD PhD

    Scott Boyd, MD PhD

    Associate Professor of Pathology

    Current Research and Scholarly Interests Our goal is to understand the lymphocyte genotype-phenotype relationships in healthy human immunity and in immunological diseases. We apply new technologies and data analysis approaches to this challenge, particularly high-throughput DNA sequencing and single-cell monoclonal antibody generation, in parallel with other functional assays.

  • Ryanne Ashley Brown, MD, MBA

    Ryanne Ashley Brown, MD, MBA

    Clinical Assistant Professor, Pathology

    Bio Ryanne Brown, M.D., M.B.A., is a Clinical Assistant Professor of Pathology and (by courtesy) Dermatology. She completed her residency training in Anatomic and Clinical Pathology followed by Surgical Pathology and Dermatopathology fellowships at Stanford. She is board certified in both Anatomic Pathology and Clinical Pathology (American Board of Pathology) and Dermatopathology (American Boards of Pathology/Dermatology). Her interests include cutaneous lymphoma and histiocytic neoplasms.

  • Jillian Buchan

    Jillian Buchan

    Clinical Assistant Professor, Pathology

    Bio Jillian is a board-certified Clinical Molecular Geneticist working in Stanford Medicine?s Clinical Genomics Program (CGP). She completed a research-based MS at University College Dublin in Ireland and later received her PhD in Molecular Genetics and Genomics in 2014 from Washington University in St. Louis. After her PhD, Jillian joined Harvard Medical School's Genetics Training Program and completed her fellowship in Clinical Molecular Genetics in 2016. Jillian then joined the Department of Pathology at Stanford School of Medicine and became board-certified by the American Board of Medical Genetics and Genomics in 2017. Her focus is on molecular-based diagnostic testing, with the majority of her time spent in the CGP, where she oversees overall laboratory operations, development of new next-generation sequencing-based clinical assays, ensures CAP/CLIA regulatory compliance, and signs out clinical test reports. She and her team launched Stanford's first clinical exome sequencing test, and the first test for the newly created CGP, in early 2018.

  • Eugene Butcher

    Eugene Butcher

    Klaus Bensch Professor in Pathology

    Current Research and Scholarly Interests Our interests include:
    1) The physiology and function of lymphocyte homing in local and systemic immunity;
    2) Biochemical and genetic studies of molecules that direct leukocyte recruitment;
    3) Chemotactic mechanisms and receptors in vascular and immune biology;
    4) Vascular control of normal and pathologic inflammation and immunity;
    5) Systems biology of immune cell trafficking and programming in tumor immunity.

  • Greg Charville, MD, PhD

    Greg Charville, MD, PhD

    Assistant Professor of Pathology at the Stanford University Medical Center

    Bio As Assistant Professor of Pathology at Stanford University School of Medicine, Dr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of disorders related to the gastrointestinal and hepatopancreatobiliary systems.

    Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular basis of human disease, focusing on genetic and epigenetic mechanisms of neoplasia.

  • Athena Cherry

    Athena Cherry

    Professor of Pathology and of Pediatrics at the Stanford University Medical Center and the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests The use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.

  • Michael Cleary

    Michael Cleary

    Lindhard Family Professor in Pediatric Cancer Biology and Professor of Pathology

    Current Research and Scholarly Interests The role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.

  • Maria Inmaculada Cobos Sillero

    Maria Inmaculada Cobos Sillero

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:

    - Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer?s disease brain

    - Investigating mechanisms of tau-related neurodegeneration in human brain

    - Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level

  • Le Cong

    Le Cong

    Assistant Professor of Pathology (Pathology Research) and of Genetics

    Bio Dr. Cong is leading a group in the Department of Pathology and Genetics at Stanford School of Medicine to pursue novel technology for scalable genome editing and single-cell genomics, and accompanying computational approaches inspired by data science. His group has a focus on studying immunology in the context of cancer and neuroscience.

    He obtained his BS with highest honor from Tsinghua University studying Electronic Engineering and then Biology, his Ph.D. from Harvard Medical School co-advised by Drs. Feng Zhang and George Church. He completed doctoral work primarily in Dr. Feng Zhang?s laboratory, where he published seminal studies on harnessing CRISPR/Cas9 for gene editing, including the most highly-cited paper in CRISPR field, with cumulative citation over 15,000 times. He has obtained over 20 issued patents as co-inventor, and his work led to one of the first FDA-approved clinical trials employing viral delivery of CRISPR/Cas9 for in vivo gene therapy. His later work applied single-cell RNA-seq to cancer drug discovery under Dr. Aviv Regev at the Broad Institute with Drs. Tyler Jacks and Vijay Kuchroo.

    Dr. Cong was a Howard Hughes Medical Institute (HHMI) International Fellow, a Cancer Research Institute (CRI) Irvington Fellow, and was selected as Forbes 30 Under 30 Asia list of young innovators, MIT TechReview TR35 China, and 2019 ?Top 10 under 40? by GEN (Genetic Engineering & Biotechnology News).

  • M. Ryan Corces

    M. Ryan Corces

    Instructor, Pathology

    Bio Dr. Corces is an instructor at Stanford University in the department of Pathology. He graduated from Princeton University in 2008 with a degree in molecular biology. He began his PhD in cancer biology at Stanford University in 2009, focusing on the genomic evolution of acute myeloid leukemia (AML) under the mentorship of Dr. Ravindra Majeti. His doctoral work led to the identification of pre-leukemic hematopoietic stem cells, which serve as the reservoir for mutation acquisition in AML. He and others have demonstrated that these pre-leukemic hematopoietic stem cells are the evolutionary ancestors to AML, they persists during remission, and may represent a novel avenue for the development of relapsed disease. Dr. Corces has continued his research at Stanford as a postdoctoral fellow under the mentorship of Dr. Howard Chang and Dr. Thomas Montine. His current research focuses on the role of the epigenome in human health and disease with a focus on cancer and neurodegenerative disease.

  • Joanne Cornbleet

    Joanne Cornbleet

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.

  • Helio Costa

    Helio Costa

    Instructor, Pathology

    Bio Helio Costa, PhD, is a geneticist with expertise in genomics, molecular biology, molecular oncology, and bioinformatics. He is currently an Instructor within the Departments of Pathology and Biomedical Data Science at Stanford Medical School. Dr. Costa's research utilizes next-generation sequencing to develop new clinical genome and transcriptome profiling methods with the end goal of translating these tools to clinical diagnostic tests for implementation at Stanford Health Care. His research group is also interested in developing data science and machine learning methods to model and predict clinical outcomes and aid in clinical decision support. He is the founding director of the Stanford Clinical Data Science Fellowship where post-doctoral fellows engage in interdisciplinary clinical research and embed in health care workflows learning, building and deploying real-world health data solutions in the Stanford Health Care system. Additionally, he is an Attending Geneticist, and Assistant Lab Director of the Molecular Genetic Pathology Laboratory for Stanford Health Care. Dr. Costa received his BS in Genetics from University of California, Davis, his PhD in Genetics from Stanford University School of Medicine, and his ABMGG Clinical Molecular Genetics and Genomics fellowship training from Stanford University School of Medicine.

  • Tina Cowan

    Tina Cowan

    Professor of Pathology (Clinical) at the Stanford University Medical Center

    Current Research and Scholarly Interests screening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.

  • Gerald Crabtree

    Gerald Crabtree

    Department of Pathology Professor in Experimental Pathology and Professor of Developmental Biology

    Current Research and Scholarly Interests Chromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin in living cells.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Dylan Dodd

    Dylan Dodd

    Assistant Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly Interests Harnessing the gut microbiome to treat human disease.

  • Lawrence Eng

    Lawrence Eng

    Professor (Research) of Pathology, Emeritus

    Current Research and Scholarly Interests Astrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.

  • Edgar Engleman

    Edgar Engleman

    Professor of Pathology and of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly Interests Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

  • Dean W. Felsher

    Dean W. Felsher

    Professor of Medicine (Oncology) and of Pathology

    Current Research and Scholarly Interests My laboratory investigates how oncogenes initiate and sustain tumorigenesis. I have developed model systems whereby I can conditionally activate oncogenes in normal human and mouse cells in tissue culture or in specific tissues of transgenic mice. In particular using the tetracycline regulatory system, I have generated a conditional model system for MYC-induced tumors. I have shown that cancers caused by the conditional over-expression of the MYC proto-oncogene regress with its inactivation.

  • Marcelo Fernandez Vina

    Marcelo Fernandez Vina

    Professor of Pathology (Research) at the Stanford University Medical Center

    Bio Marcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and current President of the International HLA & Immunogenetics Workshop. He is Section Editor of Human Immunology and an Advisory Board Member of the International Journal of Immunogenetics and Bone Marrow Transplantation.

  • Sebastian Fernandez-Pol

    Sebastian Fernandez-Pol

    Clinical Assistant Professor, Pathology

    Bio Dr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.

  • Andrew Fire

    Andrew Fire

    George D. Smith Professor in Molecular and Genetic Medicine and Professor of Pathology and of Genetics

    Current Research and Scholarly Interests We study natural cellular mechanisms for adapting to genetic change. These include systems activated during normal development and those for detecting and responding to foreign or unwanted genetic activity. Underlying these studies are questions of how a cells can distinguish information as "self" versus "nonself" or "wanted" versus "unwanted".

  • Ann Folkins

    Ann Folkins

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.

  • Steven Foung

    Steven Foung

    Professor of Pathology

    Current Research and Scholarly Interests Our research focus is define correlates of protection against hepatitis C virus and other viral pathogens. Detailed characterization of broadly neutralizing human or nonhuman primate monoclonal antibodies against these agents will create high-resolution, functional maps of linear and nonlinear epitopes comprising the major binding sites of both isolate-specific and broadly neutralizing antibodies for rational vaccine design.

  • Susan Galel

    Susan Galel

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Transfusion-transmitted infections and donor screening for infectious diseases. National policies for blood banks. Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in blood banking and transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy.

  • Stephen J. Galli, MD

    Stephen J. Galli, MD

    The Mary Hewitt Loveless, M.D. Professor in the School of Medicine and Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly Interests The goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease. We study both the roles of mast cells, basophils, and IgE in normal physiology and host defense, e.g., in responses to parasites and in enhancing resistance to venoms, and also their roles in pathology, e.g., anaphylaxis, food allergy, and asthma, both in mice and humans.

  • Sharon Markham Geaghan

    Sharon Markham Geaghan

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Pediatric Hematopathology, Pediatric Laboratory Medicine and Pathology

  • Bertil Glader

    Bertil Glader

    Professor of Pediatrics (Hematology/Oncology) and, by courtesy, of Pathology

    Current Research and Scholarly Interests Hematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.

  • Lawrence Tim Goodnough

    Lawrence Tim Goodnough

    Professor of Pathology and of Medicine (Hematology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Improving blood utilization
    Promoting alternatives to blood transfusion
    Quality improvements

  • Isabella Graef

    Isabella Graef

    Assistant Professor of Pathology

    Current Research and Scholarly Interests We are interested in addressing questions in neuronal development and function by a combination of genetic, cell biological, biochemical and chemical approaches.
    The main focus of our lab is centered around two topics: 1) the interface of signaling and gene regulation in neuronal development, with a focus on calcineurin-NFAT signaling; 2) the development of small molecules, which interfere with protein-protein interactions underlying neurodegenerative diseases.

  • Dita Gratzinger

    Dita Gratzinger

    Associate Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests I have research interests in the interaction of hematolymphoid neoplasia with the microenvironment. For example, I use a combination of immunohistochemistry, immunofluorescence and image analysis techniques to evaluate the mesenchymal stromal cell compartment in myelodysplastic syndrome (pre-leukemic bone marrow failure disorder). I also have interests in lymphoma vasculature and the tropism of lymphoma for specific types of vasculature.

  • Florette K. Gray Hazard

    Florette K. Gray Hazard

    Associate Professor of Pathology and of Pediatrics at the Stanford University Medical Center

    Current Research and Scholarly Interests My scholarly pursuits are primarily focused on the study of death and disease in the pediatric population. It is through this work that I am able to explore fundamental concepts of neoplasia, such as histogenesis and mutagenesis, while utilizing a variety of investigational techniques.

  • Michael Hendrickson

    Michael Hendrickson

    Professor of Pathology at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Diagnosis of progressive stages of uterine cancer; classification of ovarian tumors; breast cancer diagnosis and prognostic factors, soft tissue neoplasm, uterine mesenchymal neoplasm.

  • John Higgins

    John Higgins

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests I work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.

  • Marie Hollenhorst, MD, PhD

    Marie Hollenhorst, MD, PhD

    Clinical Instructor, Pathology

    Bio Dr. Hollenhorst is a physician and scientist with expertise in non-malignant hematology, transfusion medicine, and chemical biology. Dr. Hollenhorst values the one-on-one relationships that she forms with her patients, and strives to deliver the highest quality of care for individuals with blood diseases. Her experience caring for patients drives her to ask scientific questions in the laboratory, where she aims to bring a chemical approach to the study of non-malignant blood disease.

    Dr. Hollenhorst pursued combined MD and PhD training at Harvard University, where she received a PhD in Chemical Biology under the mentorship of Professor Christopher T Walsh. She subsequently completed a residency in Internal Medicine at Brigham and Women's Hospital, a fellowship in Transfusion Medicine at Harvard Medical School, and a fellowship in Hematology at Stanford.

    Dr. Hollenhorst has a particular interest in the biology of platelets, which are cellular fragments that help the blood to maintain a healthy balance between excessive bleeding and excessive clotting. Working in the laboratory of Professor Carolyn Bertozzi of Stanford Chemistry, Dr. Hollenhorst is studying sugar-containing molecules that are found within platelets and are important in controlling their function and lifespan.

    Dr. Hollenhorst's research is supported by a Stanford Chemistry, Engineering & Medicine for Human Health Physician-Scientist Fellowship, a National Institutes of Health Individual Postdoctoral Fellowship, and a National Blood Foundation Early-Career Scientific Research Grant.

  • Dikran Horoupian

    Dikran Horoupian

    Professor (Clinical) of Pathology, Emeritus

    Current Research and Scholarly Interests Neuropathology of:
    1. Neurodegenerative diseases
    2. Neurodevelopmental disorders
    3. CNS neoplasms
    4. Nerve & muscle diseases

  • Brooke Howitt

    Brooke Howitt

    Assistant Professor of Pathology at the Stanford University Medical Center

    Bio Dr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.

  • Michael Richard Howitt

    Michael Richard Howitt

    Assistant Professor of Pathology

    Current Research and Scholarly Interests Our lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.

  • Siddhartha Jaiswal

    Siddhartha Jaiswal

    Assistant Professor of Pathology

    Current Research and Scholarly Interests We identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.

  • Kristin Jensen

    Kristin Jensen

    Associate Professor of Pathology at the Palo Alto Veteran's Health Care System and at Stanford University Medical Center

    Current Research and Scholarly Interests I am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology.

  • Marisa Juntilla

    Marisa Juntilla

    Adjunct Clinical Assistant Professor, Pathology

    Current Research and Scholarly Interests My research goal is to reveal novel biology in leukemia that links cancer cell metabolism to protein translation, ultimately providing new opportunities for personalized medicine and reduced chemotherapeutic toxicity.

  • Neeraja Kambham

    Neeraja Kambham

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.

  • Chia Sui Kao

    Chia Sui Kao

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Genitourinary tumors with a special interest in Testicular tumors

  • Richard Kempson

    Richard Kempson

    Professor of Pathology, Emeritus

    Current Research and Scholarly Interests Clinicopathologic studies in endometrial carcinoma, ovarian neoplasms, and soft tissue tumors.

  • Christina Kong

    Christina Kong

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Improving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.

    Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.

    Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck.

  • Jon Kosek

    Jon Kosek

    Professor (Clinical) of Pathology, Emeritus

    Current Research and Scholarly Interests Methods of evaluation of biopsies; differentiation and, classification of neoplasms; immunohistochemistry; scanning and, transmission electron microscopy; cardiovascular pathology;, histologic assessment of bone biopsies; heart preservation and, restoration; myocardial biopsies; venous autograft coronary artery, bypass; cardial and heart valve transplantation.

  • Anandi Krishnan

    Anandi Krishnan

    Instructor, Pathology

    Current Research and Scholarly Interests Dr. Krishnan's current interests are in the transcriptional and epigenetic mechanisms of blood cell function and dysfunction in human disease. Her primary focus is on blood platelets with multifaceted function in cancer, inflammation or immunity; beyond their classical role in hemostasis and thrombosis.

    In the long term, her work aims to develop clinically-meaningful relationships between patient genomic variation, disease-specific transcriptomic variaton, and clinical phenotype in hematological diseases.

  • Joseph (Joe) Lipsick

    Joseph (Joe) Lipsick

    Professor of Pathology, of Genetics and, by courtesy, of Biology

    Current Research and Scholarly Interests Function and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.

  • Jonathan Z. Long

    Jonathan Z. Long

    Assistant Professor of Pathology

    Current Research and Scholarly Interests My laboratory studies mammalian energy and metabolic homeostasis. Our research combines classical in vitro bucket biochemistry, emerging chemical technologies, and genetic manipulations in cultured cells and in mice to uncover new pathways that control energy storage and energy use. Ultimately, we seek to translate our discoveries into therapeutic opportunities for metabolic and other chronic diseases.

  • Teri A Longacre

    Teri A Longacre

    Richard L. Kempson, MD, Professor in Surgical Pathology

    Current Research and Scholarly Interests Gynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.

  • Alarice Cheng-Yi Lowe

    Alarice Cheng-Yi Lowe

    Associate Professor of Pathology at the Stanford University Medical Center

    Bio Dr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of CTC technology to improve clinical diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.

  • Bingwei Lu

    Bingwei Lu

    Professor of Pathology

    Current Research and Scholarly Interests We are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimer’s and Parkinson’s diseases. We are using both Drosophila and mammalian models to address these fundamental questions.

  • Sara Michie

    Sara Michie

    Professor of Pathology (Research)

    Current Research and Scholarly Interests Lymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.

  • Michelle Monje

    Michelle Monje

    Associate Professor of Neurology and, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests The Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.

  • Stephen B. Montgomery

    Stephen B. Montgomery

    Associate Professor of Pathology, and of Genetics

    Current Research and Scholarly Interests We focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/

  • Thomas Montine

    Thomas Montine

    Stanford Medicine Pathology Professor

    Bio Dr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer?s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues. In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor in Pathology.

    Dr. Montine is the founding Director of the Pacific Udall Center, one of 9 NINDS-funded Morris K. Udall Centers of Excellence for Parkinson?s Disease Research. Our center performs basic, translational, and clinical research focused on cognitive impairment in Parkinson?s disease. The Pacific Udall Center emphasizes a vision for precision health that comprises functional genomics, development of surveillance tools for pre-clinical detection, and discovery of molecularly tailored therapies.

    Dr. Montine is among the top recipients of NIH funding for all Department of Pathology faculty in the United States. He was the 2015 President of the American Association of Neuropathologists, and led or co-led recent NIH initiatives to revise diagnostic guidelines for Alzheimer?s disease (NIA), develop research priorities for the National Alzheimer?s Plan (NINDS and NIA), and develop research priorities for Parkinson?s Disease (NINDS).

    The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment with the goal of defining key pathogenic steps and thereby new therapeutic targets. The Montine Laboratory addresses these prevalent, unmet medical needs through a combination of neuropathology, biomarker development and application early in the course of disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and approaches to neuroprotection. PubMed lists 579 publications for Dr. Montine. Google Scholar estimates Dr. Montine?s citations as > 38,000, his i-10 index as 355, and his H-Index as 98. NIH iCite calculates (1995 to 2017) Dr. Montine?s weighted relative citation ratio as 2041.

  • Yasodha Natkunam, M.D., Ph.D

    Yasodha Natkunam, M.D., Ph.D

    Ronald F. Dorfman, MBBch, FRCPath Professor in Hematopathology

    Current Research and Scholarly Interests My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.

  • Roberto Novoa, MD

    Roberto Novoa, MD

    Clinical Associate Professor, Pathology

    Current Research and Scholarly Interests My research interests include the medical applications of artificial intelligence, cutaneous lymphoma, and the side effects of targeted therapies. I have served as the lead dermatologist in our ongoing effort to develop AI-augmented classification of skin lesions. We are in the process of establishing one of the first prospective studies examining the performance of a deep learning algorithm in real-world patients.

  • Michael G. Ozawa

    Michael G. Ozawa

    Clinical Assistant Professor, Pathology

    Bio Dr. Ozawa is a Clinical Assistant Professor of Pathology with subspecialty focus in Cytopathology, Head and Neck pathology, and Thoracic pathology. He completed his M.D., Ph.D. training at the McGovern Medical School and the M. D. Anderson Cancer Center in Houston, TX. He then completed residency training in Anatomic and Clinical Pathology followed by fellowship training in Surgical Pathology and Cytopathology at Stanford University. He is board certified in Anatomic and Clinical Pathology as well as Cytopathology. His interests include pulmonary neoplasms as well as neoplasms of the Head and Neck. He also has developed collaborative research interests in utilizing fine needle aspiration (FNA) techniques in the growing clinical application of Chimeric Antigen T Cell (CAR-T) therapy.

Footer Links:

Stanford Medicine Resources: